Ozempic is driving up the cost of your health care, whether you can get your hands on it or not
Health-care costs are going up, and yet workers may still not get the coverage they want — particularly when it
Read MoreHealth-care costs are going up, and yet workers may still not get the coverage they want — particularly when it
Read MoreQuestions about whether Eli Lilly and Novo Nordisk can maintain their duopoly in weight loss drugs are fair game, but
Read MoreConsumers' nutritional needs are "shifting" amid the rise of weight loss drugs, which is an opportunity for food companies, Nestle
Read MoreA major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks. Source
Read MoreInvestors will be tuning into the company's fourth quarter earnings call on Feb. 6, eager to hear more about how
Read MoreDespite an 11% dive in the stock Friday, Morgan Stanley said it thinks the company "has gone through an incredible
Read MoreTwo experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly's obesity drugs. Source link
Read MoreNew obesity treatments are helping patients lose 15% or more of their body weight, and changing attitudes could expand access
Read More